LIGAND PHARMACEUTICALS INCORPORATED Contract Liability (Deferred Revenue)
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Contract Liability (Deferred Revenue) of $621.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Contract with Customer, Liability, Current $621.00K.
- 2026-03-31: Contract with Customer, Liability, Current $621.00K.
- 2025-12-31: Contract with Customer, Liability, Current $621.00K.
- 2025-09-30: Contract with Customer, Liability, Current $621.00K.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $621.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $621.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $621.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $621.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $111.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $101.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $621.00K 10-K · filed 2026-02-27 | $1.28M 10-K · filed 2025-02-28 |
| 2024-09-30 | $1.15M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.23M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.22M 10-K · filed 2025-02-28 | |
| 2023-03-31 | $257.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $355.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $9.55M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $10.58M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.50M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $654.00K 10-K · filed 2023-02-28 | $11.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | $12.01M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $17.15M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $25.11M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $29.43M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $5.40M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $8.92M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.35M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.14M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $2.23M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $939.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.81M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.29M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $2.45M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.70M 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |